Epizyme Reports Positive Data on Tazemetostat in Epithelioid Sarcoma from its Phase 2 Trial Cohort at ESMO 10/23/2018 Medications, CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 22, 2018-- Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic...
Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting 09/18/2018 Medications, NEWTON, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical...
Data age in clinical trials is about three years at publication 09/11/2018 Health News, (HealthDay)—The median data age in clinical trials in journals with a high impact factor is...
HHS chief data officer to discuss data initiative findings at Health 2.0 08/29/2018 Health News, The rise in big data has rocked nearly every sector from education to consumer tech,...